Current Perspectives Among U.S. Dermatologists on Chemoprevention of Nonmelanoma Skin Cancer: A Survey-Based Study.

Discussion: Efforts to identify effective, minimally-toxic chemopreventive agents have long been underway, but conflicting reports in the literature make formulation of validated guidelines challenging. Our study suggests differing perceptions, comfort levels, and practice strategies among U.S. dermatologists. This serves to identify areas of research requiring additional contributions from clinical investigators and reveals a need to broaden understanding of available evidence-based techniques.</p> <p><em>J Drugs Dermatol. 2017;16(5):449-452.</em></p>. PMID: 28628680 [PubMed - in process] (Source: Journal of Drugs in Dermatology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2swKWxS
via IFTTT